Diagnostic efficiency of RPA/RAA integrated CRISPR-Cas technique for COVID-19: A systematic review and meta-analysis.

Zhang, Xiaoyu; Ge, Xiao; Shen, Fangyuan; Qiao, Jinjuan; Zhang, Yubo; Li, Heng

Zhang, Xiaoyu; Ge, Xiao; Shen, Fangyuan; Qiao, Jinjuan; Zhang, Yubo; Li, Heng.

Afiliación

Zhang X; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.
Ge X; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.
Shen F; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.
Qiao J; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.
Zhang Y; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.
Li H; Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China.

PLoS One ; 17(10): e0276728, 2022.

Article en En | MEDLINE | ID: mdl-36288366

Asunto(s)

COVID-19; Humanos; COVID-19/diagnóstico; SARS-CoV-2/genética; Prueba de COVID-19; Sistemas CRISPR-Cas/genética; Recombinasas; Sensibilidad y Especificidad

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google